한방병원에 내원한 급성기 이후 코로나-19 환자 15명에 대한 임상적 특징 및 치료 분석 : 사례군 연구
Effects of Korean Medicine Treatment in Post-acute COVID-19 Syndrome: A Retrospective Case Series of 15 Patients
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objective: The aim of this study was to identify the clinical features of post-acute COVID-19 syndrome and the efficacy and safety of Korean medicine treatment. Methods: This study was conducted on 15 patients with post-acute COVID-19 syndrome who visited the outpatient Allergy, Immune, and Respiratory System Department at Kyung Hee University Korean Medicine Hospital from January 10, 2021 to April 10, 2022. We retrospectively analyzed the charts of 15 patients and collected clinical characteristics, Korean medicine treatments, outcome variables (Numeral Rating Scale (NRS), modified Medical Research Council scale (mMRC), Leicester Cough Questionnaire (LCQ), Quality of Life Visual Analog Scale (QOL-VAS), The Post-COVID-19 Functional Status (PCFS)), adverse events, etc. Results: Of the 15 patients, seven (46.7%) were men, and the average age of all patients was 49.7±13 years. The most common symptom was cough (n=9, 60%), and it was followed by dyspnea or increased respiratory effort, fatigue, insomnia, anosmia, etc. The herbal medicine was prescribed for all 15 patients, and Saengmaek-san (n=8, 53.5%) was the most prescribed. Additionally, acupuncture and cupping were performed in four patients (26.7%) each, and electroacupuncture was applied to one patient (6.7%). As a result of Korean medicine treatment, NRS, mMRC, LCQ, QOL-VAS, and PCFS showed improvement, and adverse events were mild. Conclusions: This study presented the clinical features of post-acute COVID-19 syndrome and suggested that Korean medicine treatment may be effective in alleviating related symptoms and enhancing quality of life.
Abstract
Objective: The aim of this study was to identify the clinical features of post-acute COVID-19 syndrome and the efficacy and safety of Korean medicine treatment. Methods: This study was conducted on 15 patients with post-acute COVID-19 syndrome who visited the outpatient Allergy, Immune, and Respiratory System Department at Kyung Hee University Korean Medicine Hospital from January 10, 2021 to April 10, 2022. We retrospectively analyzed the charts of 15 patients and collected clinical characteristics, Korean medicine treatments, outcome variables (Numeral Rating Scale (NRS), modified Medical Research Council scale (mMRC), Leicester Cough Questionnaire (LCQ), Quality of Life Visual Analog Scale (QOL-VAS), The Post-COVID-19 Functional Status (PCFS)), adverse events, etc. Results: Of the 15 patients, seven (46.7%) were men, and the average age of all patients was 49.7±13 years. The most common symptom was cough (n=9, 60%), and it was followed by dyspnea or increased respiratory effort, fatigue, insomnia, anosmia, etc. The herbal medicine was prescribed for all 15 patients, and Saengmaek-san (n=8, 53.5%) was the most prescribed. Additionally, acupuncture and cupping were performed in four patients (26.7%) each, and electroacupuncture was applied to one patient (6.7%). As a result of Korean medicine treatment, NRS, mMRC, LCQ, QOL-VAS, and PCFS showed improvement, and adverse events were mild. Conclusions: This study presented the clinical features of post-acute COVID-19 syndrome and suggested that Korean medicine treatment may be effective in alleviating related symptoms and enhancing quality of life.
참고문헌 (30)
- Yuki K, "COVID-19pathophysiology : A review", Clinical immunology, 215, pp.108427~ (2020)
- Hartley DM, "Public health interventions for COVID-19 : emerging evidence and implications for an evolving public health crisis", Jama, 323(19), pp.1908~1909 (2020)
- Willi S, "COVID-19 sequelae in adults aged less than 50 years : A systematic review", Travel Med Infect Dis, 40, pp.101995~ (2021)
- Central Disease Control Headquarters, "The COVID-19At-home Treatment Guideline (ver. 7)" (2022), Korea Disease Control and Prevention Agency
- Report of the WHO-China Joint Mission on Coronavirus Disease 2019(COVID-19)Swiss, "World Health Organization", World Health Organization, ~ (2020)
- Nalbandian A, "Post-acute COVID-19 syndrome", Nature medicine, 27(4), pp.601~615 (2021)
- Huang C, "6-month consequences of COVID-19in patients discharged from hospital : a cohort study", The Lancet, 397(10270), pp.220~232 (2021)
- Gupta A, "Extrapulmonary manifestations of COVID-19", Nature medicine, 26(7), pp.1017~1032 (2020)
- Logue JK, "Sequelae in adults at 6 months after COVID-19 infection", JAMA network open, 4(2), pp.e210830~ (2021)
- Al-Aly Z, "High-dimensional characterization of post-acute sequelae of COVID-19", Nature, 594(7862), pp.259~264 (2021)
- Greenhalgh T, "Management of post-acute covid-19 in primary care", bmj, 370, pp.m3026~ (2020)
- 류한성, "중증급성호흡기증후군(SARS) 및 중동호흡기증후군(MERS)의 중의 진료지침에 대한 고찰", 대한한방내과학회지, 36(3), pp.335~347 (2015), 대한한방내과학회
- Yin CS, "Introduction to the history and current status of evidence-based Korean medicine : a unique integrated system of allopathic and holistic medicine", Evidence-Based Complementary and Alternative Medicine, 2014, pp.740515~ (2014)
- Tao W, "Practice of traditional Chinese medicine for psycho-behavioral intervention improves quality of life in cancer patients : a systematic review and meta-analysis", Oncotarget, 6(37), pp.39725~39739 (2015)
- Jang SB, "Telemedicine and the Use of Korean Medicine for Patients With COVID-19in South Korea : Observational Study", JMIR Public Health and Surveillance, 7(1), pp.e20236~ (2021)
- 이경은, "코로나-19 환자의 후유증 한약 치료에 대한 고찰", 대한한방내과학회지, 42(1), pp.53~66 (2021), 대한한방내과학회[DOI]
- Klok FA, "The Post-COVID-19Functional Status scale : a tool to measure functional status over time after COVID-19", European Respiratory Journal, 56(1), pp.2001494~ (2020)
- Shah W, "Managing the long term effects of covid-19 : summary of NICE, SIGN, and RCGP rapid guideline", bmj, 372, pp.n136~ (2021)
- Datta SD, "A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection : illness beyond acute infection and public health implications", Jama, 324(22), pp.2251~2252 (2020)
- Su Y, "Multiple early factors anticipate post-acute COVID-19 sequelae", Cell, 185(5), pp.881~895 (2022)
- Sudre CH, "Attributes and predictors of long COVID", Nature medicine, 27(4), pp.626~631 (2021)
- Tenforde MW, "Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network—United States, March–June 2020", Morbidity and Mortality Weekly Report, 69(30), pp.993~ (2020)
- Li L, "Effects of chinese medicine on symptoms, syndrome evolution, and lung inflammation absorption in COVID-19 convalescent patients during 84-day follow-up after hospital discharge : a prospective cohort and nested case-control study", Chinese journal of integrative medicine, 27(4), pp.245~251 (2021)
- 李東垣, "東垣十書" (1983), Daesung Munhwa-sa
- 張介賓, "景岳全書" (2006), HANMI Medical Publishing Co
- Ji K, "Efficacy and safety of traditional Chinese medicine in idiopathic pulmonary fibrosis : a meta-analysis", Evidence-Based Complementary and Alternative Medicine, 2020, pp.1~11 (2020)
- Li F, "An integrated pathway interaction network for the combination of four effective compounds from ShengMai preparations in the treatment of cardio-cerebral ischemic diseases", Acta Pharmacologica Sinica, 36(11), pp.1337~1348 (2015)
- Tian Y, "Feasibility of Shengmai Powder in convalescent patients with novel coronavirus pneumonia", Drug Evaluation Research, 43(3), pp.378~383 (2020)
- Liu WH, "Understanding of guidance for acupuncture and moxibustion interventions on COVID-19 issued by CAAM", World journal of acupuncture-moxibustion, 30(1), pp.1~4 (2020)
- Luo X, "The add-on effect of Chinese herbal medicine on COVID-19 : a systematic review and meta-analysis", Phytomedicine, 85, pp.153282~ (2021)